AI assistant
Anika Therapeutics, Inc. — Director's Dealing 2022
Aug 11, 2022
33997_dirs_2022-08-11_1dc474a1-8783-4b39-b26a-aeae15f47ba6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anika Therapeutics, Inc. (ANIK)
CIK: 0000898437
Period of Report: 2022-08-10
Reporting Person: Levitz Michael L (EVP, CFO, Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-10 | Common Stock | M | 3859 | — | Acquired | 20423 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-10 | Restricted Stock Unit | $0.00 | M | 3859 | Disposed | Common Stock (3859) | Direct |
Footnotes
F1: Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on August 10, 2020. The 3,859 shares resulting from the RSU vest were retained in full as a result of Mr. Levitz's election to pay cash to cover the applicable taxes resulting from the RSU vest.
F2: Includes 640 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 13, 2022.
F3: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021.